Vision

To develop the most effective and affordable life-saving medicines for low-income countries, enabling access to advanced treatments for human diseases.

Mission

To discover and deliver life-saving technologies that improve and extend patients’ lives through continuous innovation and scientific excellence.

Focus Area: CAR T-Cell Therapy

Lysine Biotech is pioneering a new approach to CAR T-cell therapy—focused on affordability, safety, and effectiveness—to make advanced cancer treatments accessible to all and reduce the overall cost of care.

Learn More About Products R&D Pipline

Our Features

1.Long non coding reading frames endless RNA (lncrfeRNA)

Title: “Role of thymine in protein coding frames of mRNA sequences” published in the journal" Bioinformation. 2008. 2, 304-307. doi: 10.6026/97320630002304

— It describes a new generation of cell-based therapies where immune cells are genetically programmed to produce CARs — synthetic receptors that guide them to identify and destroy diseased cells — making them “programmable medicines.”

Learn More About Research and Development